Universitat de Lleida
    • English
    • català
    • español
  • English 
    • English
    • català
    • español
  • Login
Repositori Obert UdL
View Item 
  •   Home
  • Recerca
  • Medicina Experimental
  • Articles publicats (Medicina Experimental)
  • View Item
  •   Home
  • Recerca
  • Medicina Experimental
  • Articles publicats (Medicina Experimental)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice

Thumbnail
View/Open
Postprint (1.015Mb)
Issue date
2013
Author
Presa, Maximiliano
Zarama Ortiz, Angela
Garabatos, Nahir
Izquierdo, Cristina
Rivas, Elisa I.
Teyton, Luc
Mora Giral, Concepció
Serreze, David
Stratmann, Thomas
Suggested citation
Presa, Maximiliano; Zarama Ortiz, Angela; Garabatos, Nahir; Izquierdo, Cristina; Rivas, Elisa I.; Teyton, Luc; ... Stratmann, Thomas. (2013) . Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice. European Journal of Immunology, 2013, vol. 43, núm. 11, p. 2969-79. https://doi.org/10.1002/eji.201343633.
Impact


Web of Science logo    citations in Web of Science

Scopus logo    citations in Scopus

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
The cholera toxin B subunit (CTB) has been used as adjuvant to improve oral vaccine delivery in type 1 diabetes. The effect of CTB/peptide formulations on Ag-specific CD4+ T cells has remained largely unexplored. Here, using tetramer analysis, we investigated how oral delivery of CTB fused to two CD4+ T-cell epitopes, the BDC-2.5 T-cell 2.5mi mimotope and glutamic acid decarboxylase (GAD) 286–300, affected diabetogenic CD4+ T cells in nonobese diabetic (NOD) mice. When administered i.p., CTB-2.5mi activated 2.5mi+ T cells and following intragastric delivery generated Ag-specific Foxp3+ Treg and Th2 cells. While 2.5mi+ and GAD-specific T cells were tolerized in diabetes-resistant NODxB6.Foxp3EGFP F1 and nonobese resistant (NOR) mice, this did not occur in NOD mice. This indicated that NOD mice had a recessive genetic resistance to induce oral tolerance to both CTB-fused epitopes. In contrast to NODxB6.Foxp3EGFP F1 mice, oral treatment in NOD mice lead to strong 2.5mi+ T-cell activation and the sequestration of these cells to the effector-memory pool. Oral treatment of NOD mice with CTB-2.5mi failed to prevent diabetes. These findings underline the importance of investigating the effect of oral vaccine formulations on diabetogenic T cells as in selected cases they may have counterproductive consequences in human patients.
URI
http://hdl.handle.net/10459.1/71131
DOI
https://doi.org/10.1002/eji.201343633
Is part of
European Journal of Immunology, 2013, vol. 43, núm. 11, p. 2969-79
European research projects
Collections
  • Articles publicats (Medicina Experimental) [351]
  • Articles publicats (IRBLleida) [1170]
  • Publicacions de projectes de recerca del Plan Nacional [2958]

Contact Us | Send Feedback | Legal Notice
© 2023 BiD. Universitat de Lleida
Metadata subjected to 
 

 

Browse

All of the repositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

View Usage Statistics

D'interès

Política institucional d'accés obertDiposita les teves publicacionsDiposita dades de recercaSuport a la recerca

Contact Us | Send Feedback | Legal Notice
© 2023 BiD. Universitat de Lleida
Metadata subjected to